Glutamatergic Mechanisms of Psychosis and Target Engagement: Aim2
Latest Information Update: 19 Aug 2024
At a glance
- Drugs Ketamine (Primary) ; TS 134 (Primary)
- Indications Schizophrenia
- Focus Pharmacodynamics
- Acronyms Aim2
Most Recent Events
- 14 Aug 2024 Planned End Date changed from 15 Aug 2026 to 15 Aug 2027.
- 07 Aug 2023 Status changed from recruiting to suspended. Reason the study was stopped:In June 2023, NYSPI decided to undertake an Institute-wide safety review of human subjects research. The primary objective of the pause is to confirm that each study, in design and implementation, is appropriately protecting human subjects.
- 03 Jan 2023 Status changed from not yet recruiting to recruiting.